BREG, Inc   Report issue

For profit
Founded: Carlsbad CA United States (1989)
Status: Left NME R&D (2015)

Organization Overview

First Clinical Trial
2005
NCT00178178
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Alternative names

BREG, Inc

Active Ingredients

Drugs in Other Trials (1)

levobupivacaine (chirocaine) (1 trial)

Indications

Overview

  • Highest Phase: Phase 0
  • # of Trials: 1
  • # of Trial APIs: 1